Genetic analysis to prevent warfarin complications.
Lippi
Giuseppe
G
Salvagno
Gian Luca
GL
Guidi
Gian Cesare
GC
D000925:Anticoagulants / Q000009:adverse effects*; D001778:Blood Coagulation Disorders / Q000139:chemically induced* / Q000175:diagnosis / Q000235:genetics; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics*; D006801:Humans; D006899:Mixed Function Oxygenases / Q000235:genetics*; D064417:Vitamin K Epoxide Reductases; D014859:Warfarin
D000925:Anticoagulants; D014859:Warfarin; D003577:Cytochrome P-450 Enzyme System; D006899:Mixed Function Oxygenases; D064417:Vitamin K Epoxide Reductases
CMAJ. 2007 May 22;176(11):1589-94
17515585
Clin Med Res. 2007 Mar;5(1):8-16
17456829
Clin Chem. 2007 Jul;53(7):1199-205
17510308
Pharmacogenomics. 2007 Mar;8(3):217-25
17324110
Chest. 2004 Sep;126(3 Suppl):204S-233S
15383473
J Pharmacol Exp Ther. 2007 Aug;322(2):427-34
17496169